PharmacoMicrobiomics: The Drug-Microbiome Portal

How Bugs Modulate Drugs?

Launched on 11/11/11; Current Release 1.5 (21 Mar 2021): Spring of Hope! (Release History)

Detailed View

Summary Gut microbes (species: Prevotella copri) increase Nivolumab's response to substance.
Nivolumab (PubChem SID: 160698453)
Prevotella copri (Tax ID: 165179)
increase response to substance
Patients with non-small-cell lung carcinoma receiving nivolumab (anti–PD-1) with great diversity of gut microbiome (Alistipes putredinis, Bifidobacterium longum, and Prevotella copri) show improved response to this, manifested by high frequency of specific memory CD8+ T cell and natural killer cell subset in the periphery.

Browse Drug-Microbiome Relationship